Abeona Therapeutics (ABEO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-1993 | 12-1992 | 12-1991 | 12-1990 | 12-1989 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -3,567 | 4,254 | -680 | -2,423 | -6,555 |
| Depreciation Amortization | 24 | 30 | 23 | 33 | 41 |
| Other Working Capital | -219 | 449 | -470 | 289 | 288 |
| Other Operating Activity | 50 | 310 | 825 | -249 | 0 |
| Operating Cash Flow | $-3,712 | $5,042 | $-302 | $-2,350 | $-6,226 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -3 | -62 | -34 | -2 | -5 |
| Other Investing Activity | 0 | 0 | 0 | 298 | 14 |
| Investing Cash Flow | $-3 | $-62 | $-34 | $296 | $9 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 17 | 43 | 9 | 2,041 | 6,383 |
| Financing Cash Flow | $17 | $43 | $9 | $2,041 | $6,383 |
| Beginning Cash Position | 6,060 | 1,038 | 1,365 | 1,378 | 1,211 |
| End Cash Position | 2,362 | 6,060 | 1,038 | 1,365 | 1,378 |
| Net Cash Flow | $-3,698 | $5,022 | $-327 | $-13 | $167 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,712 | 5,042 | -302 | -2,350 | -6,226 |
| Free Cash Flow | -3,712 | 5,042 | -302 | -2,350 | -6,226 |